血脂异常
医学
糖尿病
内科学
内分泌学
极低密度脂蛋白
临床意义
脂蛋白
胆固醇
作者
Marcello Arca,Giovanni Pigna,Carla Favoccia
标识
DOI:10.2174/157016112803520864
摘要
Diabetic dyslipidemia is due to a multiple array of metabolic abnormalities determining a typical phenotype characterized by increased plasma triglycerides, reduced HDL and a preponderance of small, dense LDL. This dyslipidemia, defined as atherogenic dyslipidemia, is thought to be highly responsible for the increased cardiovascular risk in diabetes mellitus. Several lines of evidence indicate that the increased liver production of VLDL is the main underlying defect in atherogenic dyslipidemia. This review will recapitulate the pathophysiological aspects of diabetic dyslipidemia with special focus on the molecular mechanism causing increased liver production of VLDL in diabetic patients. The consequences of atherogenic dyslipidemia on mechanisms of atherogenesis will be also reviewed. Keywords: Atherogenic dyslipidemia, VLDL secretion, apoB metabolism, insulin resistance
科研通智能强力驱动
Strongly Powered by AbleSci AI